Feb 11 2008
Details about the Possibility of an Inexpensive Bird Flu Vaccine
GlaxoSmithKline, a pharmaceutical giant, has developed a low-dose and inexpensive vaccine, which could protect humans from being infected by the H5N1 bird flu virus. This virus is a severe type A influenza that has killed hundreds of people and millions of birds worldwide. A global pandemic, scientist fear, could occur if the virus mutates to [...]